The DOI matches its Crossref record; 52 of the 60 references it cites were found in a registry or an index.
Brca1 Controls Homology-Directed DNA Repair
Open accessAbstract
Germline mutations in BRCA1 confer a high risk of breast and ovarian tumors. The role of BRCA1 in tumor suppression is not yet understood, but both transcription and repair functions have been ascribed. Evidence that BRCA1 is involved in DNA repair stems from its association with RAD51, a homolog of the yeast protein involved in the repair of DNA double-strand breaks (DSBs) by homologous recombination. We report here that Brca1-deficient mouse embryonic stem cells have impaired repair of chromosomal DSBs by homologous recombination. The relative frequencies of homologous and nonhomologous DNA integration and DSB repair were also altered. The results demonstrate a caretaker role for BRCA1 in preserving genomic integrity by promoting homologous recombination and limiting mutagenic nonhomologous repair processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The tumor suppressor complex BRCA1-BARD1 functions in DNA double-strand break repair by homologous recombination.”
From BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing (2017) · cites this paper as [18]
Citations
Cites
3 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
Self-citationRetractedCressman, V. L., Backlund, D. C., Avrutskaya, A. V., Leadon, S. A., Godfrey, V., & Koller, B. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7061 · Cited by 108
Self-citationRetractedLeadon, S. A., & Avrutskaya, A. V. (1997) · PubMed · Cited by 78
RetractedThe double-strand-break repair model for recombination
Szostak, J. W., Orr-Weaver, T. L., Rothstein, R. J., & Stahl, F. W. (1983) · Cell · doi:10.1016/0092-8674(83)90331-8 · Cited by 2,437
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
XRCC3 promotes homology-directed repair of DNA damage in mammalian cellsPreprint
Pierce, A. J., Johnson, R. D., Thompson, L. H., & Jasin, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2633 · Cited by 1,384
Self-citationKinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
The Genetic Basis of Human Cancer
Vogelstein, B., & Kinzler, K. W. (1997) · Cited by 1,120
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D., Regel, E., Dinh, C. Q., Sands, A., Gregor Eichele, C., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,087
Xu, X., Ohler, Z. W., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T., & Deng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80466-9 · Cited by 819
Cited by
Sorted by citations
Items 101–200 of 999
The role of BRCA1 in transcriptional regulation and cell cycle control
Mullan, P. B., Quinn, J. E., & Harkin, D. P. (2006) · Oncogene · doi:10.1038/sj.onc.1209872 · Cited by 322
Centrosome amplification, chromosome instability and cancer development
Fukasawa, K. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.028 · Cited by 322
Chen, C.-C., Feng, W., Lim, P. X., Kass, E. M., & Jasin, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050502 · Cited by 323
Self-citationSignaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments
Yip, H. Y. K., & Papa, A. (2021) · Cells · doi:10.3390/cells10030659 · Cited by 341
Chromosomal aberrations: formation, identification and distribution
Obe, G., Pfeiffer, P., Savage, J. R. K., Johannes, C., Goedecke, W., Jeppesen, P., Natarajan, A. T., Martínez‐López, W., Folle, G. A., & Drets, M. E. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00076-3 · Cited by 309
Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes
Greenberg, R. A., Sobhian, B., Pathania, S., Cantor, S. B., Nakatani, Y., & Livingston, D. M. (2006) · Genes & Development · doi:10.1101/gad.1381306 · Cited by 308
Pathway choice in DNA double strand break repair: observations of a balancing act
Brandsma, I., & van Gent, D. C. (2012) · Genome Integrity · doi:10.1186/2041-9414-3-9 · Cited by 335
PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2
Zhang, F., Fan, Q., Ren, K., & Andreassen, P. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0123 · Cited by 303
DNA Strand Break Repair and Human Genetic Disease
McKinnon, P. J., & Caldecott, K. W. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115648 · Cited by 321
Manipulating the mammalian genome by homologous recombination
Vásquez, K. M., Marburger, K., Intödy, Z., & Wilson, J. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111009698 · Cited by 310
BRCA1 Supports XIST RNA Concentration on the Inactive X Chromosome
Ganesan, S., Silver, D. P., Greenberg, R. A., Avni, D., Drapkin, R., Miron, A., Mok, S. C., Randrianarison-Huetz, V., Brodie, S. G., Salstrom, J. L., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01052-8 · Cited by 306
Massively Parallel Functional Analysis of BRCA1 RING Domain Variants
Starita, L. M., Young, D. L., Islam, M. M., Kitzman, J. O., Gullingsrud, J., Hause, R. J., Fowler, D. M., Parvin, J. D., Shendure, J., & Fields, S. (2015) · Genetics · doi:10.1534/genetics.115.175802 · Cited by 300
Cao, L., Li, W., Kim, S., Brodie, S. G., & Deng, C.-X. (2003) · Genes & Development · doi:10.1101/gad.1050003 · Cited by 293
Cellular functions of the BRCA tumour-suppressor proteins
Boulton, S. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340633 · Cited by 299
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition
Johnson, N., Li, Y., Walton, Z. E., Cheng, K. A., Li, D., Rodig, S. J., Moreau, L. A., Unitt, C., Bronson, R. T., Thomas, H. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2377 · Cited by 293
Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2
Venkitaraman, A. R. (2014) · Science · doi:10.1126/science.1252230 · Cited by 300
Targeted therapy for cancer using PARP inhibitors
Lord, C. J., & Ashworth, A. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.016 · Cited by 288
DNA DSB repair pathway choice: an orchestrated handover mechanism
Kakarougkas, A., & Jeggo, P. A. (2013) · British Journal of Radiology · doi:10.1259/bjr.20130685 · Cited by 301
Potts, P. R., Porteus, M. H., & Yu, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601218 · Cited by 282
Paull, T. T., Cortez, D., Bowers, B., Elledge, S. J., & Gellert, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111125998 · Cited by 282
Oza, A. M., Tinker, A. V., Oaknin, A., Shapira‐Frommer, R., McNeish, I. A., Swisher, E. M., Ray-Coquard, I. L., Bell‐McGuinn, K. M., Coleman, R. L., O’Malley, D. M., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.08.022 · Cited by 286
Dong, Y., Hakimi, M., Chen, X., Kumaraswamy, E., Cooch, N. S., Godwin, A. K., & Shiekhattar, R. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00424-6 · Cited by 279
DNA Damage Response Genes and the Development of Cancer Metastasis
Broustas, C. G., & Lieberman, H. B. (2014) · Radiation Research · doi:10.1667/rr13515.1 · Cited by 284
Canny, M. D., Moatti, N., Wan, L. C. K., Fradet‐Turcotte, A., Krasner, D. S., Mateos‐Gómez, P. A., Zimmermann, M., Orthwein, A., Juang, Y.-C. A., Zhang, W., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.4021 · Cited by 273
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
Gorodetska, I., Kozeretska, I. A., & Dubrovska, A. (2019) · Journal of Cancer · doi:10.7150/jca.30410 · Cited by 302
Interaction of FANCD2 and NBS1 in the DNA damage response
Nakanishi, K., Taniguchi, T., Ranganathan, V., New, H. V., Moreau, L. A., Stotsky, M., Mathew, C. G., Kastan, M. B., Weaver, D. T., & D’Andrea, A. D. (2002) · Nature Cell Biology · doi:10.1038/ncb879 · Cited by 275
Mukhopadhyay, A., Elattar, A., Cerbinskaite, A., Wilkinson, S. J., Drew, Y., Kyle, S., Los, G., Hostomský, Z., Edmondson, R. J., & Curtin, N. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2758 · Cited by 271
Morris, J. R., & Solomon, E. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh095 · Cited by 282
Rosen, E. M., Fan, S., Pestell, R. G., & Goldberg, I. D. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10257 · Cited by 279
Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response
Reinhardt, H. C., & Yaffe, M. B. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3640 · Cited by 269
Xia, F., Taghian, D. G., DeFrank, J. S., Zeng, Z., Willers, H., Iliakis, G. E., & Powell, S. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151253498 · Cited by 263
BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance
Drost, R., Bouwman, P., Rottenberg, S., Boon, U., Schut, E., Klarenbeek, S., Klijn, C. N., van der Heijden, I., van der Gulden, H. M. L., Wientjens, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.014 · Cited by 266
Mediator function of the human Rad51B–Rad51C complex in Rad51/RPA-catalyzed DNA strand exchangePreprint
Sigurðsson, S., Komen, S. V., Bussen, W., Schild, D., Albala, J. S., & Sung, P. (2001) · Genes & Development · doi:10.1101/gad.935501 · Cited by 257
The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity
Baer, R. J. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00269-6 · Cited by 263
Elevated levels of Rad51 recombination protein in tumor cells.
Raderschall, E., Stout, K., Freier, S., Suckow, V., Schweiger, S., & Haaf, T. (2002) · PubMed · Cited by 257
BRCA1 Accelerates CtIP-Mediated DNA-End Resection
Cruz-García, A., López-Saavedra, A., & Huertas, P. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.076 · Cited by 273
ATM, a central controller of cellular responses to DNA damage
Khanna, K. K., Lavin, M. F., Jackson, S. P., & Mulhern, T. D. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400874 · Cited by 260
Clapperton, J. A., Manke, I. A., Lowery, D. M., Ho, T., Haire, L. F., Yaffe, M. B., & Smerdon, S. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb775 · Cited by 244
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
Evers, B., & Jonkers, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209871 · Cited by 264
Double-strand breaks and tumorigenesis
Pierce, A. J., Stark, J. M., Araujo, F. D., Moynahan, M. E., Berwick, M., & Jasin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02149-3 · Cited by 269
Self-citationA subset of ATM‐ and ATR‐dependent phosphorylation events requires the BRCA1 protein
Foray, N., Marot, D., Gabriel, A., Randrianarison-Huetz, V., Carr, A. M., Perricaudet, M., Ashworth, A., & Jeggo, P. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg274 · Cited by 266
Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei, M. H., Scott, S. P., Filippovitch, I., Soronika, N., Lavin, M. F., Weber, B. L., & Khanna, K. K. (2000) · PubMed · Cited by 245
Genomic integrity and the repair of double-strand DNA breaks
Pastink, A., Eeken, J. C. J., & Lohman, P. H. M. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00167-1 · Cited by 247
Homologous and non‐homologous recombination differentially affect DNA damage repair in mice
Essers, J., STEEG, H. V., de Wit, J., Swagemakers, S. M. A., Vermeij, M., Hoeijmakers, J. H. J., & Kanaar, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1703 · Cited by 247
Morganti, S., Tarantino, P., Ferraro, E., D’Amico, P., Duso, B. A., & Curigliano, G. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-24100-1_2 · Cited by 246
BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity
Shakya, R., Reid, L. J., Reczek, C. R., Cole, F., Egli, D., Lin, C.-S., deRooij, D. G., Hirsch, S., Ravi, K., Hicks, J. B., et al. (2011) · Science · doi:10.1126/science.1209909 · Cited by 244
Self-citationKristeleit, R. S., Shapiro, G. I., Burris, H. A., Oza, A. M., LoRusso, P. M., Patel, M. R., Domchek, S. M., Balmañà, J., Drew, Y., Chen, L.-M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2796 · Cited by 248
The NuRD chromatin–remodeling complex regulates signaling and repair of DNA damage
Smeenk, G., Wiegant, W. W., Vrolijk, H., Solari, A. P., Pastink, A., & van Attikum, H. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201001048 · Cited by 243
Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes
Tongelen, A. V., Loriot, A. E., & Smet, C. D. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.029 · Cited by 247
Cantor, S., Drapkin, R., Zhang, F., Lin, Y., Han, J., Pamidi, S., & Livingston, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308717101 · Cited by 240
Applying Synthetic Lethality for the Selective Targeting of Cancer
McLornan, D. P., List, A. F., & Mufti, G. J. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1407390 · Cited by 246
Functions of BRCA1 and BRCA2 in the biological response to DNA damage
Venkitaraman, A. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.20.3591 · Cited by 237
The role of BRCA1 in DNA damage response
Wu, J., Lu, L.-Y., & Yu, X. (2010) · Protein & Cell · doi:10.1007/s13238-010-0010-5 · Cited by 235
The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair
Starita, L. M. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00042-5 · Cited by 238
van Vugt, M. A. T. M., Gardino, A. K., Linding, R., Ostheimer, G. J., Reinhardt, H. C., Ong, S.-E., Tan, C. S. H., Miao, H., Keezer, S. M., Li, J., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000287 · Cited by 236
Norquist, B. M., Brady, M. F., Harrell, M. I., Walsh, T., Lee, M. K., Gülsüner, S., Bernards, S. S., Casadei, S., Burger, R. A., Tewari, K. S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1327 · Cited by 241
Hu, Y., Scully, R., Sobhian, B., Xie, A., Shestakova, E. A., & Livingston, D. M. (2011) · Genes & Development · doi:10.1101/gad.2011011 · Cited by 244
Richardson, C. A., & Jasin, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.9068-9075.2000 · Cited by 233
Self-citationMammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation
Griffin, C. S., Simpson, P. J., Wilson, C. R., & Thacker, J. (2000) · Nature Cell Biology · doi:10.1038/35036399 · Cited by 232
Zheng, L., Pan, H., Li, S., Flesken‐Nikitin, A., Chen, P., Boyer, T., & Lee, W. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00075-7 · Cited by 232
The ubiquitous role of ubiquitin in the DNA damage response
Al-Hakim, A., Escribano‐Diaz, C., Landry, M.-C., O’Donnell, L., Panier, S., Szilard, R. K., & Durocher, D. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.09.011 · Cited by 240
Jasin, M., & Haber, J. E. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.05.001 · Cited by 229
Self-citationBRCA1/2 testing: therapeutic implications for breast cancer management
Tung, N., & Garber, J. E. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0127-5 · Cited by 228
Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structurePreprint
Joo, W. S., Jeffrey, P. D., Cantor, S. B., Finnin, M. S., Livingston, D. M., & Pavletich, N. P. (2002) · Genes & Development · doi:10.1101/gad.959202 · Cited by 219
The BARD1-CstF-50 Interaction Links mRNA 3′ End Formation to DNA Damage and Tumor Suppression
Kleiman, F. E., & Manley, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00270-7 · Cited by 215
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers
Paul, A. (2014) · Frontiers in bioscience · doi:10.2741/4230 · Cited by 224
BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor
Zheng, L., Annab, L., Afshari, C., Lee, W.-H., & Boyer, T. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.171174298 · Cited by 241
Bridge, W. L., Vandenberg, C. J., Franklin, R., & Hiom, K. J. (2005) · Nature Genetics · doi:10.1038/ng1627 · Cited by 209
Control of Sister Chromatid Recombination by Histone H2AX
Xie, A., Puget, N., Shim, I., Odate, S., Jarzyna, I., Bassing, C. H., Alt, F. W., & Scully, R. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.12.007 · Cited by 211
The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair
Zhang, J., & Powell, S. N. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0192 · Cited by 213
BRCA1 mRNA Expression Levels Predict for Overall Survival in Ovarian Cancer after Chemotherapy
Quinn, J. E., James, C. R., Stewart, G. E., Mulligan, J. M., White, P., Chang, G. K. F., Mullan, P. B., Johnston, P. G., Wilson, R. H., & Harkin, D. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1083 · Cited by 207
Zhong, Q., Peng, H., Zhao, X., Zhang, L., & Hwang, W. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1816 · Cited by 209
Ye, Q., Hu, Y.-F., Zhong, H.-J., Nye, A. C., Belmont, A. S., & Li, R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108049 · Cited by 204
BRCA2-dependent and independent formation of RAD51 nuclear foci
Tarsounas, M., Davies, D. C., & West, S. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206263 · Cited by 214
Wattenberg, M. M., Asch, D., Yu, S., O'Dwyer, P. J., Domchek, S. M., Nathanson, K. L., Rosen, M. A., Beatty, G. L., Siegelman, E. S., & Reiss, K. A. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0582-7 · Cited by 211
Linking the Cellular Functions ofBRCAGenes to Cancer Pathogenesis and Treatment
Venkitaraman, A. R. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151422 · Cited by 201
Kais, Z., Rondinelli, B., Holmes, A. L., O’Leary, C., Kozono, D., D’Andrea, A. D., & Ceccaldi, R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.031 · Cited by 208
Tracing the network connecting brca and fanconi anaemia proteins
Venkitaraman, A. R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1321 · Cited by 202
BRCA1 Phosphorylation by Aurora-A in the Regulation of G2 to M Transition
Ouchi, M., Fujiuchi, N., Sasai, K., Katayama, H. G., Minamishima, Y. A., Ongusaha, P. P., Deng, C., Sen, S., Lee, S. W., & Ouchi, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311780200 · Cited by 199
RetractedSnouwaert, J. N., Gowen, L. C., Latour, A. M., Mohn, A. R., Xiao, A., DiBiase, L., & Koller, B. H. (1999) · Oncogene · doi:10.1038/sj.onc.1203334 · Cited by 197
Self-citationTutt, A. N. J., Lord, C. J., McCabe, N., Farmer, H., Turner, N. C., Martin, N. M. B., Jackson, S. P., Smith, G. C. M., & Ashworth, A. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.012 · Cited by 198
Regulatory ubiquitylation in response to DNA double-strand breaks
Panier, S., & Durocher, D. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.013 · Cited by 203
Regulation of DNA repair in hypoxic cancer cells
Bindra, R. S., Crosby, M. E., & Glazer, P. M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9061-3 · Cited by 194
Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer
Morlando, M., & Fatica, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020570 · Cited by 197
Page, F. L., Randrianarison-Huetz, V., Marot, D., Cabannes, J., Perricaudet, M., Feunteun, J., & Sarasin, A. R. (2000) · PubMed · Cited by 190
DNA replication-dependent nuclear dynamics of the Mre11 complex.
Mirzoeva, O. K., & Petrini, J. H. J. (2003) · PubMed · Cited by 188
Roles of ATP binding and ATP hydrolysis in human Rad51 recombinase function
Chi, P., Komen, S. V., Sehorn, M. G., Sigurðsson, S., & Sung, P. (2006) · DNA repair · doi:10.1016/j.dnarep.2005.11.005 · Cited by 197
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
Zhang, P., Wang, L., Rodriguez‐Aguayo, C., Yuan, Y., Debeb, B. G., Chen, D., Sun, Y., You, M. J., Liu, Y., Dean, D. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6671 · Cited by 188
Brodie, S. G., Xu, X., Qiao, W., Li, W.-M., Cao, L., & Deng, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204929 · Cited by 188
Lessons learned from BRCA1 and BRCA2
Zheng, L., Li, S., Boyer, T., & Lee, W. (2000) · Oncogene · doi:10.1038/sj.onc.1203968 · Cited by 187
Treatment of triple negative breast cancer (TNBC): current options and future perspectives
Laurentiis, M. D., Cianniello, D., Caputo, R., Stanzione, B., Arpino, G., Cinieri, S., Lorusso, V., & Placido, S. D. (2010) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(10)70025-6 · Cited by 186
Grompe, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.20.2253 · Cited by 189
Rare Mutations in XRCC2 Increase the Risk of Breast Cancer
Park, D. J., Lesueur, F., Nguyen‐Dumont, T., Pertesi, M., Odefrey, F., Hammet, F., Neuhausen, S. L., John, E. M., Andrulis, I. L., Terry, M. B., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.02.027 · Cited by 195
Cohen, P. E., Pollack, S. E., & Pollard, J. W. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0017 · Cited by 189
BRCA1 haploinsufficiency for replication stress suppression in primary cells
Pathania, S., Bade, S., Guillou, M. L., Burke, K. A., Reed, R., Bowman-Colin, C., Su, Y., Ting, D. T., Polyák, K., Richardson, A. L., et al. (2014) · Nature Communications · doi:10.1038/ncomms6496 · Cited by 183
Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro
Lee, K., Wang, D., Lippard, S. J., & Sharp, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072068399 · Cited by 182
PARP inhibitors: New partners in the therapy of cancer and inflammatory diseases
Peralta-Leal, A., Rodríguez-Vargas, J. M., Aguilar‐Quesada, R., Rodríguez, M. I., Linares, J. L., de Almodóvar, M. R., & Oliver, F. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.04.008 · Cited by 189
Allen, C., Kurimasa, A., Brenneman, M. A., Chen, D. J., & Nickoloff, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052545899 · Cited by 181
Recombination factors of Saccharomyces cerevisiae
Sung, P., Trujillo, K. M., & Van Komen, S. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(00)00054-3 · Cited by 180
Metadata
- Authors
- Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Jasin, Maria
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 1999-10
- Volume
- 4
- Issue
- 4
- Pages
- 511-518
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2059365987
- Cited by
- 1,245
- References
- 60
- Citations by year
- 2026: 27 · 2025: 18 · 2024: 22 · 2023: 35 · 2022: 21 · 2021: 42 · 2020: 47 · 2019: 48 · 2018: 53 · 2017: 47 · 2016: 47 · 2015: 45 · 2014: 55 · 2013: 58 · 2012: 47
- FWCI
- 22.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- National Cancer Institute (1P50CA68425, P50CA068425)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, homologous recombination, homology-directed repair, DNA double-strand break repair, RAD51, non-homologous end joining, genome stability, tumor suppression, mouse embryonic stem cells, germline mutations, breast and ovarian cancer
- MeSH terms
- Animals, Arabinofuranosyluracil, Cell Line, Chromosomes, DNA Damage, DNA Repair, DNA-Binding Proteins, Mutation, Proto-Oncogene Proteins, Recombination, Genetic, Stem Cells, Thymidine Kinase, Transfection, Retinoblastoma Protein, Mice, Knockout, Gene Targeting, BRCA1 Protein, Rad51 Recombinase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review